CJC-1295 w/o DAC
$60.00
CJC-1295 (without DAC) is a short-acting GHRH analog studied for enhancing pulsatile GH release and IGF-1 activity in metabolic and recovery research.
Out of stock
Description
CJC-1295 (Without DAC)
Strength Options: 5mg
Purity: ≥98%
Form: Lyophilized powder for reconstitution
Use: For laboratory research only
Description
CJC-1295 without DAC (Drug Affinity Complex) is a short-acting Growth Hormone-Releasing Hormone (GHRH) analog studied for its ability to promote pulsatile GH release without prolonged half-life extension. It is commonly used in tandem with GHRPs (like Ipamorelin) to mimic natural GH secretion patterns in research settings.
CJC-1295 (no DAC) is studied in models focused on:
-
Growth hormone stimulation and IGF-1 expression
-
Muscle growth and repair
-
Fat metabolism and recovery support
-
Shorter GH release windows to minimize desensitization
Suggested Research Protocol (for investigational use only)
-
Typical Dose Studied: 100–300mcg per injection
-
Frequency: 1–3x daily, often combined with a GHRP
-
Administration: Subcutaneous (SC) route explored
Storage Guidelines
-
Store lyophilized peptide at -20°C
-
After reconstitution, refrigerate at 2–8°C
-
Avoid light, moisture, and repeated freeze-thaw cycles
⚠️ Legal Disclaimer
This product is sold strictly for laboratory research purposes only. It is not intended for human consumption, medical, veterinary, or diagnostic use. All information is provided for scientific and educational reference. By purchasing, you agree to handle this material in compliance with all applicable laws and regulations.
Additional information
Weight | 0.1 kg |
---|
Reviews
There are no reviews yet.